keyword
MENU ▼
Read by QxMD icon Read
search

Estimulacion

keyword
https://www.readbyqxmd.com/read/30250311/-medicina-supresora-y-medicina-estimulante-una-mirada-penetrante-de-la-pr%C3%A3-ctica-m%C3%A3-dica
#1
Leonardo Viniegra-Velázquez
La teoría de la medicina supresora (MS) y la medicina estimulante (ME) destaca dos formas radicalmente distintas de entender la enfermedad y de enfrentarla. Para la MS es un objeto extraño o ajeno al organismo que hay que disminuir o destruir (suprimir); para la ME es un trastorno de la armonía interna que requiere fortalecer o avivar el organismo para restablecerla (estimular). En la medicina moderna, el poder de la industria de la salud favorece el predominio de la MS, por su alta rentabilidad, y la marginación de las medicinas alternativas (MA), poco rentables que, al igual que la vacunación o las terapias sustitutivas y regenerativas, son formas de ME...
2018: Boletín Médico del Hospital Infantil de México
https://www.readbyqxmd.com/read/29566135/european-heart-rhythm-association-ehra-position-paper-on-arrhythmia-management-and-device-therapies-in-endocrine-disorders-endorsed-by-asia-pacific-heart-rhythm-society-aphrs-and-latin-american-heart-rhythm-society-lahrs
#2
Bulent Gorenek, Giuseppe Boriani, Gheorge-Andrei Dan, Laurent Fauchier, Guilherme Fenelon, He Huang, Gulmira Kudaiberdieva, Gregory Y H Lip, Rajiv Mahajan, Tatjana Potpara, Juan David Ramirez, Marc A Vos, Francisco Marin
Endocrine disorders are associated with various tachyarrhythmias, including atrial fibrillation (AF), ventricular tachycardia (VT), ventricular fibrillation (VF), and bradyarrhythmias. Along with underlying arrhythmia substrate, electrolyte disturbances, glucose, and hormone levels, accompanying endocrine disorders contribute to development of arrhythmia. Arrhythmias may be life-threatening, facilitate cardiogenic shock development and increase mortality. The knowledge on the incidence of tachy- and bradyarrhythmias, clinical and prognostic significance as well as their management is limited; it is represented in observational studies and mostly in case reports on management of challenging cases...
June 1, 2018: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/29212110/antithrombotic-therapy-in-atrial-fibrillation-associated-with-valvular-heart-disease-executive-summary-of-a-joint-consensus-document-from-the-european-heart-rhythm-association-ehra-and-european-society-of-cardiology-working-group-on-thrombosis-endorsed-by-the
#3
Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, Laurent Fauchier, Deirdre A Lane, Torben B Larsen, Francisco Marin, Joao Morais, Calambur Narasimhan, Brian Olshansky, Luc Pierard, Tatjana Potpara, Nizal Sarrafzadegan, Karen Sliwa, Gonzalo Varela, Gemma Vilahur, Thomas Weiss, Giuseppe Boriani, Bianca Rocca
Management strategies for patients with atrial fibrillation (AF) in association with valvular heart disease (VHD) have been less informed by randomized trials, which have largely focused on ‘non-valvular AF’ patients. Thromboembolic risk also varies according to valve lesion and may also be associated with CHA2DS2-VASc score risk factor components, rather than only the valve disease being causal. Given the need to provide expert recommendations for professionals participating in the care of patients presenting with AF and associated VHD, a task force was convened by the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group (WG) on Thrombosis, with representation from the ESC WG on Valvular Heart Disease, Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) with the remit to comprehensively review the published evidence, and to produce a consensus document on the management of patients with AF and associated VHD, with up-to-date consensus statements for clinical practice for different forms of VHD, based on the principles of evidence-based medicine...
December 2017: Thrombosis and Haemostasis
https://www.readbyqxmd.com/read/29096024/antithrombotic-therapy-in-atrial-fibrillation-associated-with-valvular-heart-disease-a-joint-consensus-document-from-the-european-heart-rhythm-association-ehra-and-european-society-of-cardiology-working-group-on-thrombosis-endorsed-by-the-esc-working-group
#4
REVIEW
Gregory Y H Lip, Jean Philippe Collet, Raffaele de Caterina, Laurent Fauchier, Deirdre A Lane, Torben B Larsen, Francisco Marin, Joao Morais, Calambur Narasimhan, Brian Olshansky, Luc Pierard, Tatjana Potpara, Nizal Sarrafzadegan, Karen Sliwa, Gonzalo Varela, Gemma Vilahur, Thomas Weiss, Giuseppe Boriani, Bianca Rocca
Atrial fibrillation (AF) is a major worldwide public health problem, and AF in association with valvular heart disease (VHD) is also common. However, management strategies for this group of patients have been less informed by randomized trials, which have largely focused on 'non-valvular AF' patients. Thrombo-embolic risk also varies according to valve lesion and may also be associated with CHA2DS2VASc score risk factor components, rather than only the valve disease being causal. Given marked heterogeneity in the definition of valvular and non-valvular AF and variable management strategies, including non-vitamin K antagonist oral anticoagulants (NOACs) in patients with VHD other than prosthetic heart valves or haemodynamically significant mitral valve disease, there is a need to provide expert recommendations for professionals participating in the care of patients presenting with AF and associated VHD...
November 1, 2017: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/27578566/-multidisciplinary-meeting-about-the-use-of-direct-oral-anticoagulants-in-nonvalvular-atrial-fibrillation
#5
REVIEW
Humberto Rodríguez-Reyes, Antonio Arauz-Góngora, Enrique Asensio-Lafuente, Manuel de Jesús Celaya-Cota, Alejandro Cordero-Cabra, Milton Guevara-Valdivia, Raúl Izaguirre-Avila, Susano Lara-Vaca, Vitelio Mariona-Moreno, Enrique Martínez-Flores, Santiago Nava-Townsend, Gerardo Pozas-Garza, Gerardo Rodríguez-Diez
Knowing the real impact of atrial fibrillation in the stroke, the Sociedad Mexicana of Electrofisiología y Estimulación Cardiaca (SOMEEC) had the initiative to develop a multidisciplinary meeting of experts the with the purpose to update the available scientific evidence from clinical practice guidelines, meta-analyses, controlled clinical trials, and complementing with the experience and views of a group of experts. To meet this goal, SOMEEC gathered a group of specialists in the area of cardiology, electrophysiology, neurology and hematology that given their experience in certain areas, they share the scientific evidence with the panel of experts to leave open a discussion about the information presented in this article...
April 2017: Archivos de Cardiología de México
https://www.readbyqxmd.com/read/27571678/-not-available
#6
Cristina V Torres Díaz, Gonzalo Martín Peña, Elena Ezquiaga, Marta Navas García, Rafael García de Sola
Gracias a los avances técnicos en técnicas neuroquirúrgicas, y debido a que el diagnóstico y la clasificación de las enfermedades psiquiátricas han evolucionado significativamente a lo largo de las últimas décadas, se están desarrollando tratamientos a nivel experimental para aquellos pacientes resistentes al manejo conservador.La anorexia nerviosa es una enfermedad de prevalencia creciente, con la tasa de mortalidad más elevada dentro de los trastornos psiquiátricos, y con aproximadamente un 20% de pacientes que presentan una evolución tórpida...
July 19, 2016: Nutrición Hospitalaria: Organo Oficial de la Sociedad Española de Nutrición Parenteral y Enteral
https://www.readbyqxmd.com/read/26108807/cardiac-tachyarrhythmias-and-patient-values-and-preferences-for-their-management-the-european-heart-rhythm-association-ehra-consensus-document-endorsed-by-the-heart-rhythm-society-hrs-asia-pacific-heart-rhythm-society-aphrs-and-sociedad-latinoamericana-de-estimulaci%C3%A3
#7
REVIEW
Deirdre A Lane, Luis Aguinaga, Carina Blomström-Lundqvist, Giuseppe Boriani, Gheorge-Andrei Dan, Mellanie True Hills, Elaine M Hylek, Stephen A LaHaye, Gregory Y H Lip, Trudie Lobban, John Mandrola, Pamela J McCabe, Susanne S Pedersen, Ron Pisters, Simon Stewart, Kathryn Wood, Tatjana S Potpara, Bulent Gorenek, Jamie Beth Conti, Roberto Keegan, Suzannah Power, Jeroen Hendriks, Philippe Ritter, Hugh Calkins, Francesco Violi, Jodie Hurwitz
No abstract text is available yet for this article.
December 2015: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/22030341/-spanish-pacemaker-registry-eighth-official-report-of-the-spanish-society-of-cardiology-working-group-on-cardiac-pacing-2010
#8
REVIEW
Raúl Coma Samartín, Maria José Sancho-Tello de Carranza, Francisco Ruiz Mateas, Juan Leal del Ojo González, Maria Luisa Fidalgo Andrés et al.
INTRODUCTION AND OBJECTIVES: Our aim is to describe the analysis of the pacemaker implants and replacements reported to the Spanish Pacemaker Registry in 2010, with special reference to the selection of pacing modes. METHODS: Data collection was based on the information provided by the European Pacemaker Patient Identification Card, which was processed using a specially designed computer application. RESULTS: Information was received from 101 hospitals, covering a total of 11 648 cards...
December 2011: Revista Española de Cardiología
https://www.readbyqxmd.com/read/19744963/efficacy-and-safety-of-pallidal-stimulation-in-primary-dystonia-results-of-the-spanish-multicentric-study
#9
MULTICENTER STUDY
F Valldeoriola, I Regidor, A Mínguez-Castellanos, E Lezcano, P García-Ruiz, A Rojo, A Salvador, A Castro, F Grandas, J Kulisevsky, M J Martí, P Martínez-Martín, L Relova, J Rumià, A Cámara, J A Burguera, G Linazasoro, J López de Val, J Obeso, M C Rodríguez-Oroz, E Tolosa
BACKGROUND: Dystonia is a complex clinical syndrome originated by a wide range of aetiologies. The diagnosis of dystonia is made after the evaluation of aetiological, phenomenological and genetic factors. Medications, except in patients with dopa-responsive dystonia, are of limited efficacy. Botulinum toxin injections are not applicable to patients with generalised dystonia, since many muscular groups contribute to disability. Clinical studies in children and adults with primary generalised dystonia (PGD) have reported beneficial effects of bilateral GPi deep brain stimulation (DBS) in both motor symptoms and disability produced by dystonia as well as a favourable impact of DBS in the health-related quality of life (HRQoL)...
January 2010: Journal of Neurology, Neurosurgery, and Psychiatry
https://www.readbyqxmd.com/read/11485722/-pallidal-and-subthalamic-stimulation-in-parkinson-s-disease-lessons-from-the-unsatisfactory-results
#10
(no author information available yet)
BACKGROUND: Deep brain stimulation is being widely used in advanced Parkinson's disease (PD). Outcome determinants are not known. OBJECTIVE: Some relevant data about outcome may be obtained from the study of patients with unsatisfactory results. PATIENTS AND METHODS: We have retrospectively analyzed the number and causes of unsatisfactory results (insufficient improvement 6 months after the intervention) in 211 patients. RESULTS: Forty patients (18...
August 2001: Neurología: Publicación Oficial de la Sociedad Española de Neurología
https://www.readbyqxmd.com/read/193445/-3h-isoproterenol-binding-to-subcellular-fractions-of-mouse-parotid-relationship-to-cyclic-nucleotide-formation-and-the-stimulation-of-dna-synthesis
#11
COMPARATIVE STUDY
J P Durham, N Galanti
(3H) Isoproterenol binding to subcellular fractions of mouse parotid: Relationship to cyclic nucleotide formation and the stimulation of DNA synthesis. (Unión the (3H) Isoproterenol a fracciones subcelulares de parótida de ratón y su relacón con la formacón de nucleótidos cíclicos y la estimulación de la síntesis de DNA). Arch. Biol. Med. Exper. 10: 105-114, 1976. Tritiated isoproterenol binds to all subcellular fractions of mouse parotid but 70% of the binding is to the nuclear fraction. Binding to other mouse tissues was less than to the parotid...
December 1976: Archivos de Biología y Medicina Experimentales
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"